Welcome to our dedicated page for MINIMED GROUP SEC filings (Ticker: MMED), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MINIMED GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MINIMED GROUP's regulatory disclosures and financial reporting.
MiniMed Group, Inc. director Brett A. Wall filed an initial Form 3 to report his status as an insider of the company. The filing does not list any reportable transactions or derivative positions, indicating that this document serves primarily as a baseline ownership and affiliation disclosure.
MiniMed Group, Inc. filed an initial ownership report for director Walter Matthew R. This Form 3 filing for ticker MMED identifies him as a director of the company. The filing does not report any specific stock transactions or holdings, serving only as a baseline disclosure of insider status.
MiniMed Group, Inc. director Mauri Laura has filed an initial insider ownership report on Form 3 for shares of MMED. The filing lists Mauri as a director and reports no insider stock transactions or derivative positions in the data provided.
MiniMed Group, Inc. director Timothy A. Wicks filed an initial ownership report on Form 3. The filing does not list any common stock or derivative transactions, serving as a baseline disclosure of his status as a director of the company.
MiniMed Group, Inc. filed an initial Form 3 for director Robert (Bob) Hopkins, formally registering him as an insider of the company. The filing shows no reported purchases, sales, gifts, exercises, or other transactions, and lists no derivative securities positions in the provided data.
MiniMed Group, Inc. director D. Keith Grossman filed an initial Form 3 insider ownership report for MMED. This filing establishes his status as a director and provides a baseline disclosure of his beneficial ownership. The report shows no insider transactions or derivative positions in this submission.
MiniMed Group, Inc. director Glenn A. Eisenberg filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as a reporting insider of the company. The filing does not list any equity transactions or existing derivative positions.
MiniMed Group, Inc. director Kevin E. Lofton filed an initial Form 3 reporting his status as an insider of the company. The filing does not list any common stock or derivative holdings and shows no reported purchases, sales, exercises, gifts, or other transactions.
MiniMed Group, Inc. officer Gyurci John filed an initial Form 3 reporting his status as a company officer. This is a baseline ownership filing required when someone becomes subject to insider reporting rules. The filing does not report any transactions or derivatives positions in MiniMed Group stock.
MiniMed Group, Inc. filed an initial insider ownership report for officer Chandrasena Gillian on Form 3. The data provided shows no reported transactions, no buy or sell activity, and no derivative positions, indicating this filing is primarily a baseline disclosure of status as an officer.